{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:59:03Z","timestamp":1787313543440,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Amgen K.K"},{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00198-022-06472-1","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T07:02:37Z","timestamp":1656745357000},"page":"2205-2216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-5266","authenticated-orcid":false,"given":"Saeko","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Buchanan-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"6472_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","volume":"7","author":"H Orimo","year":"2012","unstructured":"Orimo H, Nakamura T, Hosoi T et al (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis\u2013executive summary. Arch Osteoporos 7:3\u201320. https:\/\/doi.org\/10.1007\/s11657-012-0109-9","journal-title":"Arch Osteoporos"},{"key":"6472_CR2","volume-title":"Japanese guidelines for the prevention and treatment of osteoporosis","author":"Committee of Japanese Guidelines fo","year":"2015","unstructured":"Committee of Japanese Guidelines for the Prevention and Treatment of Osteoporosis (2015) Japanese guidelines for the prevention and treatment of osteoporosis, 2015th edn. Life Science Publishing, Tokyo, Japan, pp 2\u20133 (in Japanese)","edition":"2015"},{"key":"6472_CR3","unstructured":"International Osteoporosis Foundation (n.d.) Fragility fractures epidemiology. https:\/\/www.osteoporosis.foundation\/health-professionals\/fragility-fractures\/epidemiology. Accessed 2 June\u00a02021"},{"key":"6472_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382. https:\/\/doi.org\/10.1016\/j.bone.2004.03.024","journal-title":"Bone"},{"key":"6472_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739. https:\/\/doi.org\/10.1359\/jbmr.2000.15.4.721","journal-title":"J Bone Miner Res"},{"key":"6472_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ard.2008.092775","volume":"68","author":"TA van Geel","year":"2009","unstructured":"van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99\u2013102. https:\/\/doi.org\/10.1136\/ard.2008.092775","journal-title":"Ann Rheum Dis"},{"key":"6472_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","volume":"28","author":"H Johansson","year":"2017","unstructured":"Johansson H, Siggeirsd\u00f3ttir K, Harvey NC, Od\u00e9n A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28:775\u2013780. https:\/\/doi.org\/10.1007\/s00198-016-3868-0","journal-title":"Osteoporos Int"},{"key":"6472_CR8","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/jbmr.1698","volume":"27","author":"JA Eisman","year":"2012","unstructured":"Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039\u20132046. https:\/\/doi.org\/10.1002\/jbmr.1698","journal-title":"J Bone Miner Res"},{"key":"6472_CR9","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K \u00c5kesson","year":"2013","unstructured":"\u00c5kesson K, Marsh D, Mitchell PJ, McLellan A, Stenmark J, Pierroz D, Kyer C, Cooper C (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152. https:\/\/doi.org\/10.1007\/s00198-013-2348-z","journal-title":"Osteoporos Int"},{"key":"6472_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","volume":"32","author":"N Li","year":"2021","unstructured":"Li N, Hiligsmann M, Boonen A, van Oostwaard M, de Bot R, Wyers C, Bours S, van den Bergh J (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32:1517\u20131530","journal-title":"Osteoporos Int"},{"key":"6472_CR11","unstructured":"University of Sheffield Centre for Metabolic Bone Diseases (2008) FRAX\u00ae Fracture risk assessment tool. https:\/\/www.sheffield.ac.uk\/FRAX\/. Accessed 11 Nov 2019"},{"key":"6472_CR12","doi-asserted-by":"publisher","first-page":"e0256379","DOI":"10.1371\/journal.pone.0256379","volume":"16","author":"T Sobue","year":"2021","unstructured":"Sobue T, Fukuda H, Matsumoto T, Lee B, Ito S, Iwata S (2021) The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan. PLoS ONE 16:e0256379. https:\/\/doi.org\/10.1371\/journal.pone.0256379","journal-title":"PLoS ONE"},{"key":"6472_CR13","unstructured":"Medical Data Vision Co. (2017) Press release - overview of database. https:\/\/www.mdv.co.jp\/press\/2017\/detail_728.html. Accessed 25 Feb 2021"},{"key":"6472_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11657-018-0456-2","volume":"13","author":"Y Taguchi","year":"2018","unstructured":"Taguchi Y, Inoue Y, Kido T, Arai N (2018) Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis. Arch Osteoporos 13:45. https:\/\/doi.org\/10.1007\/s11657-018-0456-2","journal-title":"Arch Osteoporos"},{"key":"6472_CR15","doi-asserted-by":"publisher","first-page":"e018553","DOI":"10.1136\/bmjopen-2017-018553","volume":"8","author":"K Imai","year":"2018","unstructured":"Imai K, Petigara T, Kohn MA, Nakashima K, Aoshima M, Shito A, Kanazu S (2018) Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases. BMJ Open 8:e018553. https:\/\/doi.org\/10.1136\/bmjopen-2017-018553","journal-title":"BMJ Open"},{"key":"6472_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3820\/jjpe.21.23","volume":"21","author":"M Nakamura","year":"2016","unstructured":"Nakamura M (2016) Utilization of MDV data and data quality control. Japan Pharmacoepidemiol 21:23\u201325. https:\/\/doi.org\/10.3820\/jjpe.21.23","journal-title":"Japan Pharmacoepidemiol"},{"key":"6472_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00223-011-9545-6","volume":"90","author":"H Hagino","year":"2011","unstructured":"Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2011) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14\u201321. https:\/\/doi.org\/10.1007\/s00223-011-9545-6","journal-title":"Calcif Tissue Int"},{"key":"6472_CR18","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","volume":"31","author":"RL Barron","year":"2020","unstructured":"Barron RL, Oster G, Grauer A, Crittenden DB, Weycker D (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31:2103\u20132111. https:\/\/doi.org\/10.1007\/s00198-020-05294-3","journal-title":"Osteoporos Int"},{"key":"6472_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00198-018-4732-1","volume":"30","author":"A Balasubramanian","year":"2019","unstructured":"Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30:79\u201392. https:\/\/doi.org\/10.1007\/s00198-018-4732-1","journal-title":"Osteoporos Int"},{"key":"6472_CR20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","volume":"29","author":"JA Kanis","year":"2018","unstructured":"Kanis JA, Johansson H, Od\u00e9n A, Harvey NC, Gudnason V, Sanders KM, Sigurdsson G, Siggeirsdottir K, Fitzpatrick LA, Borgstr\u00f6m F (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747\u20131757. https:\/\/doi.org\/10.1007\/s00198-018-4502-0","journal-title":"Osteoporos Int"},{"key":"6472_CR21","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/13696998.2020.1831517","volume":"23","author":"JA Park","year":"2020","unstructured":"Park JA, Nam JH, Hong SH, Shim YB, Jeong J, Shin JY (2020) Economic burden of subsequent fracture in osteoporosis patients in South Korea. J Med Econ 23:1598\u20131605. https:\/\/doi.org\/10.1080\/13696998.2020.1831517","journal-title":"J Med Econ"},{"key":"6472_CR22","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/jbmr.4414","volume":"36","author":"S Khalid","year":"2021","unstructured":"Khalid S, Pineda-Moncus\u00ed M, El-Hussein L, Delmestri A, Ernst M, Smith C, Libanati C, Toth E, Javaid MK, Cooper C (2021) Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models. J Bone Miner Res 36:2162\u20132176","journal-title":"J Bone Miner Res"},{"key":"6472_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jbmr.4432","volume":"37","author":"L Iconaru","year":"2022","unstructured":"Iconaru L, Charles A, Baleanu F, Surquin M, Benoit F, Mugisha A, Moreau M, Paesmans M, Karmali R, Rubinstein M (2022) Prediction of an imminent fracture after an index fracture\u2013models derived from the Frisbee cohort. J Bone Miner Res 37:59\u201367","journal-title":"J Bone Miner Res"},{"key":"6472_CR24","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/jbmr.3528","volume":"33","author":"KH Rubin","year":"2018","unstructured":"Rubin KH, M\u00f6ller S, Holmberg T, Bliddal M, S\u00f8ndergaard J, Abrahamsen B (2018) A new fracture risk assessment tool (FREM) based on public health registries. J Bone Miner Res 33:1967\u20131979","journal-title":"J Bone Miner Res"},{"key":"6472_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00198-021-06165-1","volume":"33","author":"S M\u00f6ller","year":"2022","unstructured":"M\u00f6ller S, Skj\u00f8dt MK, Yan L, Abrahamsen B, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA, Rubin KH (2022) Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM). Osteoporos Int 33:57\u201366","journal-title":"Osteoporos Int"},{"key":"6472_CR26","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1007\/s11999-011-1780-7","volume":"469","author":"PM Cawthon","year":"2011","unstructured":"Cawthon PM (2011) Gender differences in osteoporosis and fractures. Clin Orthop Relat Res 469:1900\u20131905. https:\/\/doi.org\/10.1007\/s11999-011-1780-7","journal-title":"Clin Orthop Relat Res"},{"key":"6472_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/jbmr.3953","volume":"35","author":"E Toth","year":"2020","unstructured":"Toth E, Banefelt J, \u00c5kesson K, Sp\u00e5ngeus A, Orts\u00e4ter G, Libanati C (2020) History of previous fracture and imminent fracture risk in Swedish women aged 55 to 90 years presenting with a fragility fracture. J Bone Miner Res 35:861\u2013868. https:\/\/doi.org\/10.1002\/jbmr.3953","journal-title":"J Bone Miner Res"},{"key":"6472_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cdtm.2015.02.006","volume":"1","author":"MX Ji","year":"2015","unstructured":"Ji MX, Yu Q (2015) Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med 1:9\u201313. https:\/\/doi.org\/10.1016\/j.cdtm.2015.02.006","journal-title":"Chronic Dis Transl Med"},{"key":"6472_CR29","doi-asserted-by":"publisher","first-page":"115286","DOI":"10.1016\/j.bone.2020.115286","volume":"134","author":"E S\u00f6reskog","year":"2020","unstructured":"S\u00f6reskog E, Str\u00f6m O, Sp\u00e5ng\u00e9us A, \u00c5kesson KE, Borgstr\u00f6m F, Banefelt J, Toth E, Libanati C, Charokopou M (2020) Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone 134:115286. https:\/\/doi.org\/10.1016\/j.bone.2020.115286","journal-title":"Bone"},{"key":"6472_CR30","doi-asserted-by":"publisher","first-page":"e000014","DOI":"10.1136\/rmdopen-2014-000014","volume":"1","author":"K Briot","year":"2015","unstructured":"Briot K, Roux C (2015) Glucocorticoid-induced osteoporosis. RMD Open 1:e000014. https:\/\/doi.org\/10.1136\/rmdopen-2014-000014","journal-title":"RMD Open"},{"key":"6472_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1590\/s1807-59322010001100024","volume":"65","author":"RM Pereira","year":"2010","unstructured":"Pereira RM, Carvalho JF, Canalis E (2010) Glucocorticoid-induced osteoporosis in rheumatic diseases. Clin (Sao Paulo) 65:1197\u20131205. https:\/\/doi.org\/10.1590\/s1807-59322010001100024","journal-title":"Clin (Sao Paulo)"},{"key":"6472_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/2042098613486829","volume":"4","author":"MR de Jong","year":"2013","unstructured":"de Jong MR, Van der Elst M, Hartholt KA (2013) Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf 4:147\u2013154. https:\/\/doi.org\/10.1177\/2042098613486829","journal-title":"Ther Adv Drug Saf"},{"key":"6472_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society (2019) Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67:674\u2013694. https:\/\/doi.org\/10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"key":"6472_CR34","doi-asserted-by":"publisher","first-page":"906274","DOI":"10.1155\/2013\/906274","volume":"2013","author":"NE Allen","year":"2013","unstructured":"Allen NE, Schwarzel AK, Canning CG (2013) Recurrent falls in Parkinson\u2019s disease: a systematic review. Parkinsons Dis 2013:906274. https:\/\/doi.org\/10.1155\/2013\/906274","journal-title":"Parkinsons Dis"},{"key":"6472_CR35","doi-asserted-by":"publisher","first-page":"e0161689","DOI":"10.1371\/journal.pone.0161689","volume":"11","author":"L Kalilani","year":"2016","unstructured":"Kalilani L, Asgharnejad M, Palokangas T, Durgin T (2016) Comparing the incidence of falls\/fractures in Parkinson\u2019s disease patients in the US population. PLoS ONE 11:e0161689. https:\/\/doi.org\/10.1371\/journal.pone.0161689","journal-title":"PLoS ONE"},{"key":"6472_CR36","first-page":"564","volume":"9","author":"DM Zhao","year":"2016","unstructured":"Zhao DM, Cheng P, Zhu B (2016) Epilepsy and fracture risk: a meta-analysis. Int J Clin Exp Med 9:564\u2013569","journal-title":"Int J Clin Exp Med"},{"key":"6472_CR37","first-page":"214","volume":"18","author":"R Camicioli","year":"2004","unstructured":"Camicioli R, Licis L (2004) Motor impairment predicts falls in specialized Alzheimer care units. Alzheimer Dis Assoc Disord 18:214\u2013218","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"6472_CR38","unstructured":"Qunibi WY (2020) Overview of chronic kidney disease-mineral and bone disorder (CKD-MBD). UpToDate. https:\/\/www.uptodate.com\/contents\/overview-of-chronic-kidney-disease-mineral-and-bone-disorder-ckd-mbd. Accessed 2 Mar 2021"},{"key":"6472_CR39","unstructured":"Dawson-Hughes B (2021) Vitamin D deficiency in adults: definition, clinical manifestations, and treatment. UpToDate. https:\/\/www.uptodate.com\/contents\/vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment. Accessed 22 Mar 2021"},{"key":"6472_CR40","doi-asserted-by":"publisher","unstructured":"Avenell A, Mak JC, O'Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014:CD000227. https:\/\/doi.org\/10.1002\/14651858.CD000227.pub4","DOI":"10.1002\/14651858.CD000227.pub4"},{"key":"6472_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1507\/endocrj.43.211","volume":"43","author":"M Shikari","year":"1996","unstructured":"Shikari M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2 years\u2019 treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43:211\u2013220. https:\/\/doi.org\/10.1507\/endocrj.43.211","journal-title":"Endocr J"},{"key":"6472_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/bf03324586","volume":"17","author":"F Richy","year":"2005","unstructured":"Richy F, Deroisy R, Lecart MP, Hanssens L, Mawet A, Reginster JY (2005) D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clin Exp Res 17:133\u2013142. https:\/\/doi.org\/10.1007\/bf03324586","journal-title":"Aging Clin Exp Res"},{"key":"6472_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2147\/dddt.S84264","volume":"10","author":"Z Xu","year":"2016","unstructured":"Xu Z, Fan C, Zhao X, Tao H (2016) Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials. Drug Des Devel Ther 10:509\u2013517. https:\/\/doi.org\/10.2147\/dddt.S84264","journal-title":"Drug Des Devel Ther"},{"key":"6472_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/acer.13000","volume":"40","author":"GW Gaddini","year":"2016","unstructured":"Gaddini GW, Turner RT, Grant KA, Iwaniec UT (2016) Alcohol: a simple nutrient with complex actions on bone in the adult skeleton. Alcohol Clin Exp Res 40:657\u2013671. https:\/\/doi.org\/10.1111\/acer.13000","journal-title":"Alcohol Clin Exp Res"},{"key":"6472_CR45","doi-asserted-by":"publisher","first-page":"e025806","DOI":"10.1136\/bmjopen-2018-025806","volume":"9","author":"R Nishimura","year":"2019","unstructured":"Nishimura R, Kato H, Kisanuki K, Oh A, Hiroi S, Onishi Y, Guelfucci F, Shimasaki Y (2019) Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study. BMJ Open 9:e025806. https:\/\/doi.org\/10.1136\/bmjopen-2018-025806","journal-title":"BMJ Open"},{"key":"6472_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1534-9","volume":"19","author":"I Kawachi","year":"2019","unstructured":"Kawachi I, Okamoto S, Sakamoto M, Ohta H, Nakamura Y, Iwasaki K, Yoshida M, Hiroi S, Ogino M (2019) Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database. BMC Neurol 19:1\u201310. https:\/\/doi.org\/10.1186\/s12883-019-1534-9","journal-title":"BMC Neurol"},{"key":"6472_CR47","unstructured":"ClinRisk Ltd (2016) QFracture Risk Calculator. https:\/\/qfracture.org\/. Accessed 22 Mar 2021"},{"key":"6472_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bimj.201700067","volume":"60","author":"G Heinze","year":"2018","unstructured":"Heinze G, Wallisch C, Dunkler D (2018) Variable selection\u2013a review and recommendations for the practicing statistician. Biom J 60:431\u2013449. https:\/\/doi.org\/10.1002\/bimj.201700067","journal-title":"Biom J"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06472-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06472-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06472-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T04:11:30Z","timestamp":1665115890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06472-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6472"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06472-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient data are de-identified at the hospital level before being incorporated into the MDV database, and the medical claims data retrieved from the database for this study were unlinkable to individual patients. Furthermore, as there was no active enrolment, follow-up, or direct data collection from individuals, ethics committee approval for this study was not necessary. Formal consent from patients for participation and publication was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Saeko Fujiwara received consultation fees from Teijin Pharma Co. Amy Buchanan-Hughes, Alvin Ng and Jennifer Page are employees of Costello Medical, which was funded by Amgen to provide data analysis, research, writing and editorial services for this manuscript. Kenji Adachi is an employee of Amgen, and Hong Li was an employee of Amgen at the time of study conduct and manuscript development.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}